Clinical Trial Update: Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

This update describes a Phase 1 trial evaluating Zanzalintinib in combination with ipilimumab and nivolumab for metastatic soft tissue sarcoma, currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Zanzalintinib (Zanzalintinib)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Metastatic Soft-tissue Sarcoma | Phase 1 | Status: RECRUITING